GlassScriptPhysician profile
Dean B Levitan
NPI 1528014685
$3,962.78
in general payments reported to CMS, 2019-2025
22 companies · $442 in 2025
The $442 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $312 · 2021: $789 · 2022: $708 · 2023: $957 · 2024: $488 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,719 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,719.08 |
| Education | $167.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,110.29 | 2019-2025 | |
| Daiichi Sankyo INC. | $518.15 | 2019-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $387.82 | 2023-2025 | |
| Therapeuticsmd, INC. | $293.57 | 2020-2022 | |
| Astellas Pharma US INC | $289.63 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $274.74 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $178.05 | 2021-2022 | |
| Hologic Sales and Service, LLC | $153.95 | 2020-2025 | Myosure Tissue Removal Device, Coolseal Generator, Aptima |
| Pfizer INC. | $146.99 | 2019-2024 | |
| Organon LLC | $115.34 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $103.27 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $97.74 | 2019-2025 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Merck Sharp & Dohme LLC | $92.90 | 2019-2025 | Gardasil 9, Gardasil |
| Agile Therapeutics, INC. | $40.85 | 2023 | Twirla |
| Shield Therapeutics INC | $24.83 | 2023 | Accrufer |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24.09 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.64 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.56 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.18 | 2023 | |
| Allergan, INC. | $19.46 | 2019 | |
| Evofem Biosciences, INC. | $15.36 | 2022 | |
| Coloplast Corp | $14.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Levitan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.